Published in Life Sci on November 26, 2004
Toxic effects of Carthamus tinctorius L. (Safflower) extract on mouse spermatogenesis. J Assist Reprod Genet (2012) 0.98
Carthamus tinctorius Enhances the Antitumor Activity of Dendritic Cell Vaccines via Polarization toward Th1 Cytokines and Increase of Cytotoxic T Lymphocytes. Evid Based Complement Alternat Med (2011) 0.84
The effects of Carthamus tinctorius L. on placental histomorphology and survival of the neonates in mice. Avicenna J Phytomed (2012) 0.84
Evaluation of effectiveness of herbal medication in cancer care: a review study. Iran J Cancer Prev (2012) 0.83
Effects of hormone deprivation and 2-methoxyestradiol combination therapy on hormone-dependent prostate cancer in vivo. Neoplasia (2005) 0.81
Chemotherapeutic activities of Carthami Flos and its reversal effect on multidrug resistance in cancer cells. Afr J Tradit Complement Altern Med (2013) 0.76
Effects of Carthamus tinctorius L. on the ovarian histomorphology and the female reproductive hormones in mice. Avicenna J Phytomed (2013) 0.75
Awareness and current knowledge of breast cancer. Biol Res (2017) 0.75
Efficacy and safety of lapatinib as first-line therapy for ErbB2-amplified locally advanced or metastatic breast cancer. J Clin Oncol (2008) 3.83
Effects of estrogen depletion on angiogenesis in estrogen-receptor-positive breast carcinoma--an immunohistochemical study of vasohibin-1 and CD31 with correlation to pathobiological response of the patients in neoadjuvant aromatase inhibitor therapy. Expert Opin Ther Targets (2012) 2.00
Breast cancer in limited-resource countries: an overview of the Breast Health Global Initiative 2005 guidelines. Breast J (2006) 1.85
The cell cycle checkpoint gene Rad9 is a novel oncogene activated by 11q13 amplification and DNA methylation in breast cancer. Cancer Res (2005) 1.27
Thymidine phosphorylase (platelet-derived endothelial-cell growth factor) in cancer biology and treatment. Lancet Oncol (2005) 1.26
Her2/neu expression predicts the response to antiaromatase neoadjuvant therapy in primary breast cancer: subgroup analysis from celecoxib antiaromatase neoadjuvant trial. Clin Cancer Res (2004) 1.04
Gene polymorphism and protein of human pro- and anti-inflammatory cytokines in Chinese healthy subjects and chronic periodontitis patients. J Transl Med (2012) 0.98
The Breast Cancer Working Group presentation was divided into three sections: the epidemiology, pathology and treatment of breast cancer. Jpn J Clin Oncol (2010) 0.92
Effect of Sanguisorba officinalis L on breast cancer growth and angiogenesis. Expert Opin Ther Targets (2012) 0.91
Tumor-derived aberrant methylation in plasma of invasive ductal breast cancer patients: clinical implications. Oncol Rep (2003) 0.90
Association of matrix metalloproteinase (MMP-1, MMP-3 and MMP-9) and cyclooxygenase-2 gene polymorphisms and their proteins with chronic periodontitis. Arch Oral Biol (2011) 0.90
Relationship of CD44+CD24-/low breast cancer stem cells and axillary lymph node metastasis. J Transl Med (2012) 0.90
E-cadherin promoter methylation can regulate its expression in invasive ductal breast cancer tissue in Chinese woman. Life Sci (2002) 0.89
Overexpression of epithelial growth factor receptor (EGFR) predicts better response to neo-adjuvant chemotherapy in patients with triple-negative breast cancer. J Transl Med (2012) 0.87
Chrysomya bezziana: a rare infestation of the breast. Breast J (2007) 0.86
Rhodiola algida improves chemotherapy-induced oral mucositis in breast cancer patients. Expert Opin Investig Drugs (2010) 0.85
Pro-inflammatory cytokine, matrix metalloproteinases and TIMP-1 are involved in wound healing after mastectomy in invasive breast cancer patients. Biomed Pharmacother (2007) 0.85
Association of matrix metalloproteinase (MMP)-1, 3, 9, interleukin (IL)-2, 8 and cyclooxygenase (COX)-2 gene polymorphisms with chronic periodontitis in a Chinese population. Cytokine (2012) 0.84
Application of a nanotechnology antimicrobial spray to prevent lower urinary tract infection: a multicenter urology trial. J Transl Med (2012) 0.84
Epigenetic change in E-cadherin and COX-2 to predict chronic periodontitis. J Transl Med (2010) 0.83
Presence of extensive intraductal component in patients undergoing breast conservative surgery predicts presence of residual disease in subsequent completion mastectomy. Chin Med J (Engl) (2009) 0.83
Comparative evaluation of cytokines in gingival crevicular fluid and saliva of patients with aggressive periodontitis. Int J Biol Markers (2013) 0.83
Changes in protein expression after neoadjuvant use of aromatase inhibitors in primary breast cancer: a proteomic approach to search for potential biomarkers to predict response or resistance. Expert Opin Investig Drugs (2010) 0.83
Possible predictive markers related to micro-metastasis in breast cancer patients. Oncol Rep (2006) 0.82
Trastuzumab: updates and future issues. Cancer Chemother Pharmacol (2005) 0.81
Increased expression of annexin I is associated with drug-resistance in nasopharyngeal carcinoma and other solid tumors. Proteomics Clin Appl (2009) 0.81
Fructus Schisandrae (Wuweizi) containing compound in modulating human lymphatic system - a Phase I minimization clinical trial. Biomed Pharmacother (2007) 0.81
Using association rules mining to explore pattern of Chinese medicinal formulae (prescription) in treating and preventing breast cancer recurrence and metastasis. J Transl Med (2012) 0.80
Minimally invasive video-assisted thyroidectomy for the early-stage differential thyroid carcinoma. J Transl Med (2012) 0.80
Decreased expression of C-erbB-2 and CXCR4 in breast cancer after primary chemotherapy. J Transl Med (2012) 0.79
Clinical application of human β-defensin and CD14 gene polymorphism in evaluating the status of chronic inflammation. J Transl Med (2012) 0.79
Preoperative systemic therapy in locoregional management of early breast cancer: highlights from the Kyoto Breast Cancer Consensus Conference. Breast Cancer Res Treat (2012) 0.79
Surgery-related shedding of breast cancer cells as determined by RT-PCR assay. J Surg Oncol (2003) 0.79
Correlation of epigenetic change and identification of risk factors for oral submucous fibrosis. Int J Biol Markers (2012) 0.79
Production of matrix metalloproteinases in specific subpopulations of human-patient breast cancer invading in three dimensional culture system. Life Sci (2004) 0.79
Pattern of alternative medicine usage among the Chinese breast cancer patients: implication for service integration. Am J Chin Med (2003) 0.78
Down-regulation of heat-shock protein 70 (HSP-70) correlated with responsiveness to neoadjuvant aromatase inhibitor therapy in breast cancer patients. Anticancer Res (2010) 0.78
Fructus schisandrae (Wuweizi)-containing compound inhibits secretion of HBsAg and HBeAg in hepatocellular carcinoma cell line. Biomed Pharmacother (2007) 0.78
Breast sentinel lymph node biopsy using radioisotope injection: is one-day better than two-day protocol? Am Surg (2003) 0.78
Effects of Shugansanjie Tang on matrix metalloproteinases 1, 3 and 9 and telomerase reverse transcriptase expression in human breast cells in vitro. Biomed Pharmacother (2007) 0.77
Expression of CD44V6 in parotid pleomorphic adenoma and carcinoma ex pleomorphic adenoma. Expert Opin Investig Drugs (2010) 0.77
Expression of thymidine phosphorylase and dihydropyrimidine dehydrogenase in human breast carcinoma cells and tissues. Anticancer Res (2009) 0.77
Mouse model of plasma cell mastitis. J Transl Med (2012) 0.77
Association of cytokines, high sensitive C-reactive protein, VEGF and beta-defensin-1 gene polymorphisms and their protein expressions with chronic periodontitis in the Chinese population. Int J Biol Markers (2013) 0.77
Suppression of C6 gliomas via application of rat hyperplasia gene. Int J Biol Markers (2014) 0.77
Epigenetic changes of TIMP-3, GSTP-1 and 14-3-3 sigma genes as indication of status of chronic inflammation and cancer. Int J Biol Markers (2014) 0.77
Phase II study of an 'all-oral' regimen of capecitabine, idarubicin and cyclophosphamide for metastatic breast cancer--safety, efficacy and quality of life. Oncology (2005) 0.76
Evaluation of the psychological and biological changes of patients diagnosed with benign and malignant breast tumors. Int J Biol Markers (2012) 0.76
Sentinel lymph node technique for breast cancer: radiation safety issues. Semin Oncol (2004) 0.76
Angiotensin II induces interleukin-6 synthesis in osteoblasts through ERK1/2 pathway via AT1 receptor. Arch Oral Biol (2010) 0.76
A rat cell line derived from DMBA-induced mammary carcinoma. Life Sci (2003) 0.76
Combination of radiological and biochemical methods to assess bone mineral density of mandible in fully edentulous patients after chemotherapy: a 5-year prospective study. Expert Opin Investig Drugs (2010) 0.76
Emodin affects ERCC1 expression in breast cancer cells. J Transl Med (2012) 0.76
New developments in breast cancer prognosis: molecular predictors of treatment response and survival. Int J Biol Markers (2013) 0.76
Neoadjuvant chemotherapy for breast cancer determined by chemosensitivity assay achieves better tumor response. Biomed Pharmacother (2007) 0.76
Author's response. Expert Opin Ther Targets (2013) 0.75
Comparing serum levels of cardiac biomarkers in cancer patients receiving chemotherapy and subjects with chronic periodontitis. J Transl Med (2012) 0.75
Breast cancer management: the way forward. Hong Kong Med J (2009) 0.75
Effects of capecitabine and vinorelbine on cell proliferation, metabolism and COX2 and p16 expression in breast cancer cell lines and solid tumour tissues. Biomed Pharmacother (2007) 0.75
Radix bupleuri containing compound (KY88 liver-livo) induces apoptosis and production of interleukin-4 and tumor necrosis factor-alpha in liver cancer cells in vitro. Am J Chin Med (2004) 0.75
Evaluation of therapeutic efficacy of capecitabine on human breast carcinoma tissues and cell lines in vitro. Biomed Pharmacother (2007) 0.75
Development of breast cancer therapy: biomarker-driven and response-guided approaches in a neoadjuvant setting. Int J Biol Markers (2015) 0.75
Correlation of tumor-infiltrative lymphocyte subtypes alteration with neoangiogenesis before and after neoadjuvant chemotherapy treatment in breast cancer patients. Int J Biol Markers (2014) 0.75
Case report: postradiation chondrosarcoma with a short latency period of 6 months. Int J Biol Markers (2014) 0.75
Translational research to realize the full potential of novel agents--an opportunity for vinflunine? Expert Opin Drug Saf (2011) 0.75
Combat against cancer with science and medicine. Expert Opin Investig Drugs (2010) 0.75
Novel insights in clinical trials with preoperative systemic therapy for primary breast cancer. Biomed Pharmacother (2004) 0.75
A pilot study: application of hemoglobin and cortisol levels, and a memory test to evaluate the quality of life of breast cancer patients on chemotherapy. Int J Biol Markers (2013) 0.75
Sentinel lymph node biopsy or detection of micrometastasis in bone marrow: which might be an alternative to axillary lymph node dissection in breast cancer patients? Asian J Surg (2004) 0.75
Status of oral ulcerative mucositis and biomarkers to monitor posttraumatic stress disorder effects in breast cancer patients. Int J Biol Markers (2013) 0.75
Personalization of loco-regional care for primary breast cancer patients (part 1). Future Oncol (2015) 0.75
Personalization of loco-regional care for primary breast cancer patients (part 2). Future Oncol (2015) 0.75
Application of interleukin-1 genes and proteins to monitor the status of chronic periodontitis. Int J Biol Markers (2013) 0.75
Clinical experience with docetaxel for Chinese breast cancer patients: hematological toxicity profiles. Breast Cancer (2006) 0.75
Comparison of TPS with CEA and CA 15.3 in follow-up of Chinese breast cancer patients. Anticancer Res (2002) 0.75
Arimidex inhibition on proliferation of human breast solid tumors measured by ATP bioluminescence. Life Sci (2004) 0.75
Outcomes of adjuvant endocrine therapy and hormone receptor status change following neoadjuvant chemotherapy in breast cancer patients. Int J Biol Markers (2014) 0.75
Application of image-guided biopsy for impalpable breast lesions in Chinese women. ANZ J Surg (2003) 0.75
Sentinel lymph node biopsy -- here to stay. Asian J Surg (2004) 0.75